GB Patent

GB201017363D0 — Injection devices

Assigned to Owen Mumford Ltd · Expires 2010-11-24 · 15y expired

What this patent protects

An injection device includes an elongate housing (10), a syringe (12) disposed in the housing, and an internal piston (20) to express a dose from a needle (16) at its front end. The injection device further includes a shroud element (24) movable forwardly relative to the syringe …

USPTO Abstract

An injection device includes an elongate housing (10), a syringe (12) disposed in the housing, and an internal piston (20) to express a dose from a needle (16) at its front end. The injection device further includes a shroud element (24) movable forwardly relative to the syringe to shroud the needle after use and a latch (74) movable between a latched state in which it restricts rearward movement of the shroud element, and a release state. The latch is moved to its latch state by a magnetic force (56).

Drugs covered by this patent

Patent Metadata

Patent number
GB201017363D0
Jurisdiction
GB
Classification
Expires
2010-11-24
Drug substance claim
No
Drug product claim
No
Assignee
Owen Mumford Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.